Sly Saint
Senior Member (Voting Rights)
In health-care settings, psychological interventions are commonly used to treat a wide range of mental health conditions, ranging from mild reactions to stressors, to severe mental and physical health conditions. There are estimated to be more than 1000 different psychological approaches (some being minor variations of the others) based on a range of psychological concepts and theories of change.1
In most cases of developing a new psychological intervention,
a manual is generated and disseminated that reports information about the psychological techniques used, the number and duration of sessions, and the specific content of those sessions.2 Often studies are done to assess a new intervention’s beneficial and harmful effects, the cost-effectiveness of its uptake in different settings, and its core effective elements.3 However, for new psychological interventions, the pathway from development to assessment and dissemination for use in practice does not follow any commonly accepted criteria.
There are no specific standards about the type and quantity of evidence required before a new psychological intervention is made available for everyday use. For pharmacological interventions, market release of new medications is regulated by formal rules and methodological requirements developed by national and international regulatory agencies.4 Not only are there well defined criteria for establishing efficacy and assessing tolerability and side-effects of new medications, but also marketing authorisation is granted for restricted use, outlining that a positive benefit–harm balance has been established for a specific clinical condition only.5 An absence of regulatory requirements for new psychological interventions might have several negative consequences.
https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(20)30414-4/fulltextFirst, newly developed psychological interventions
might be disseminated in the absence of evidence about their efficacy and tolerability. Harmful consequences might include: worsening of symptomatology; negative
changes in family, occupation, or general adjustment in life; or adverse effects.6
Second, psychological interventions supported by evidence of efficacy for a specific clinical condition, context, or population group, might be used in other conditions and contexts, for which evidence of efficacy and tolerability has not been established. Third, treatment manuals might not be disseminated or accessible, and psychological
interventions might therefore not be properly implemented in practice.3
Scientific societies and international or national public health organisations should join efforts to develop specific standards about the type and quantity of evidence required before a new psychological intervention, its treatment manual, and related implementation tools, are made available for everyday use in clinical practice.
sci-hub.se/10.1016/S2215-0366(20)30414-4
("develop specific standards about the type and quantity of evidence required" imo quality needs to be in there; eg getting non-psych hps to review the evidence)